Fresenius SE Receivables 2016-2023 | FSNUY

Fresenius SE receivables from 2016 to 2023. Receivables can be defined as the total amount of collectibles for a company
  • Fresenius SE receivables for the quarter ending September 30, 2023 were $4.529B, a 44.8% decline year-over-year.
  • Fresenius SE receivables for 2022 were $7.549B, a 11.28% decline from 2021.
  • Fresenius SE receivables for 2021 were $8.509B, a 5.7% increase from 2020.
  • Fresenius SE receivables for 2020 were $8.05B, a 1.22% decline from 2019.
Fresenius SE Annual Receivables
(Millions of US $)
2022 $7,549
2021 $8,509
2020 $8,050
2019 $8,149
2018 $7,758
2017 $7,029
2016 $5,605
2015 $5,190
Fresenius SE Quarterly Receivables
(Millions of US $)
2023-09-30 $4,529
2023-06-30 $8,407
2023-03-31 $8,447
2022-12-31 $7,549
2022-09-30 $8,205
2022-06-30 $8,530
2022-03-31 $8,959
2021-12-31 $8,509
2021-09-30 $8,906
2021-06-30 $9,033
2021-03-31 $9,375
2020-12-31 $8,050
2020-09-30 $8,538
2020-06-30 $8,070
2020-03-31 $8,607
2019-12-31 $8,149
2019-09-30 $8,031
2019-06-30 $8,123
2019-03-31 $8,456
2018-12-31 $7,758
2018-09-30 $7,663
2018-06-30 $8,057
2018-03-31 $8,451
2017-12-31 $7,029
2017-09-30 $7,175
2017-06-30 $6,546
2017-03-31 $6,712
2016-12-31 $5,605
2016-09-30 $5,487
2016-06-30 $5,468
2016-03-31 $5,409
2015-12-31 $5,190
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $21.379B $24.011B
Fresenius SE & Co is a health care company. It offers products and services for dialysis, hospitals and outpatient treatment. The company's business segment consists of Fresenius Medical Care is engaged in treating with chronic kidney failure; Fresenius Helios is a hospital operator; Fresenius Kabi supplies essential drugs, clinical nutrition products, medical devices and services and Fresenius Vamed plans, develops and manages healthcare facilities. Fresenius SE & Co is headquartered in Bad Homburg, Germany.
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $17.308B 17.75
DaVita (DVA) United States $13.689B 16.84
Encompass Health (EHC) United States $9.303B 22.88
Chemed (CHE) United States $8.694B 26.73
Elanco Animal Health (ELAN) United States $7.242B 16.28
Option Care Health (OPCH) United States $5.321B 26.14
RadNet (RDNT) United States $4.963B 117.74
Amedisys (AMED) United States $3.181B 22.75
Astrana Health (ASTH) United States $2.805B 39.69
LifeStance Health (LFST) United States $2.579B 0.00
Addus HomeCare (ADUS) United States $2.399B 29.12
U.S Physical Therapy (USPH) United States $1.274B 34.50
Pennant (PNTG) United States $1.057B 50.71
Aveanna Healthcare Holdings (AVAH) United States $1.022B 0.00
Atai Life Sciences (ATAI) Germany $0.208B 0.00
Daxor (DXR) United States $0.045B 0.00
ATI Physical Therapy (ATIP) United States $0.025B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.019B 0.00
Psychemedics (PMD) United States $0.014B 0.00
Ontrak (OTRK) United States $0.010B 0.00
Novo Integrated Sciences (NVOS) United States $0.006B 0.00
IMAC Holdings (BACK) United States $0.002B 0.00